ImmuCell Corporation

NASDAQ: ICCC · Real-Time Price · USD
6.09
-0.63 (-9.38%)
At close: Aug 15, 2025, 3:59 PM
6.19
1.64%
After-hours: Aug 15, 2025, 04:10 PM EDT

ImmuCell Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
4.6M 3.76M 3.81M 1.32M 960.35K 978.74K 1.99M 1.45M 3.1M 5.79M 8.83M 11.04M 11.82M 10.19M 10.5M 10.7M 6.81M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -468 n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
45.42K 33.37K 30.53B 37.68K 182.72K 57.65K 70.04K 82.46K 87.78K 76.63K 24.57K 23.78K 23K 26.11K 26.6K 25.39K 23.39K
Receivables
3.4M 3.81M 2.31M 1.97M 2.68M 2.19M 2.01M 1.52M 2.14M 1.8M 1.74M 1.44M 2.66M 2.72M 2.44M 2.06M 2.48M
Inventory
7.36M 7.11M 7.46M 7.3M 7.15M 7.81M 7.39M 7.54M 6.33M 6.04M 5.32M 4.6M 3.44M 3.09M 2.67M 2.42M 2.12M
Other Current Assets
n/a n/a 33.34K n/a 136.48K 39.73K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 800.00
Total Current Assets
15.92M 15.04M 13.89M 10.79M 11.21M 11.47M 11.96M 10.95M 12.25M 13.99M 16.43M 17.33M 18.3M 16.26M 16.08M 15.53M 11.81M
Property-Plant & Equipment
29.55M 29.91M 30.41M 30.9M 31.53M 32.15M 32.37M 32.84M 30.64M 30.64M 29.79M 28.47M 28.21M 28M 27.95M 27.99M 27.6M
Goodwill & Intangibles
109.89K 114.66K 119.44K 124.21K 128.99K 133.76K 138.54K 143.32K 148.09K 152.87K 157.65K 162.42K 167.2K 171.97K 176.75K 181.53K 186.3K
Total Long-Term Assets
29.7M 30.06M 30.56B 31.06M 31.84M 32.34M 32.58M 33.06M 30.87M 30.87M 29.97M 28.66M 28.4M 28.2M 28.16M 28.2M 27.81M
Total Assets
45.62M 45.1M 44.45M 41.86M 43.05M 43.81M 44.55M 44.01M 43.12M 44.86M 46.4M 45.98M 46.7M 44.47M 44.23M 43.73M 39.62M
Account Payables
986.11K 943.64K 883.21K 438.15K 721.23K 874.56K 779.85K 918.4K 794.85K 790K 759.34K 643.88K 662.07K 745.04K 703.38K 536.79K 743.19K
Deferred Revenue
n/a n/a n/a n/a 4.39K 3.05K -1.85B -2.05B n/a n/a n/a n/a n/a -745.04K -1.38M n/a n/a
Short-Term Debt
1.52M 1.5M 1.48M 1.46M 1.44M 1.43M 1.41M 2.09M 2.06M 1.04M 998.16K 967K 947.28K 812.21K 782.52K 774.99K 767.52K
Other Current Liabilities
n/a 337.37K n/a n/a 16.11K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Liabilities
3.87M 4.41M 4.47M 4.56M 4.18M 4.2M 3.33M 4.19M 3.84M 3.07M 2.71M 2.51M 2.35M 2.53M 2.17M 2.03M 2.1M
Long-Term Debt
8.65M 9.04M 9.42M 9.8M 10.17M 10.54M 10.9M 8.64M 8.92M 9.19M 9.48M 9.73M 9.98M 8.33M 8.55M 8.35M 8.54M
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
12.76M 13.17M 13.57M 13.84M 14.23M 14.62M 15.2M 12.96M 11.12M 11.41M 11.7M 10.7M 10.98M 9.35M 9.6M 9.43M 9.65M
Total Liabilities
16.63M 17.58M 18.04M 18.4M 18.41M 18.82M 18.53M 17.15M 14.96M 14.48M 14.42M 13.21M 13.33M 11.89M 11.77M 11.46M 11.75M
Total Debt
14.66M 15.1M 15.53M 15.84M 16.27M 16.69M 16.68M 15.1M 13.22M 12.48M 12.73M 11.78M 12.03M 10.27M 10.49M 10.31M 10.52M
Common Stock
904.59K 904.24K 889.64K 789.64K 781.42K 781.42K 781.42K 781.42K 781.42K 781.42K 781.42K 781.42K 781.42K 781.42K 781.42K 781.42K 729.9K
Retained Earnings
-12.72M n/a -14.68M -13.98M -12.44M -12.01M -10.87M -9.93M -8.55M -6.23M -4.56M -3.69M -3M -3.74M -3.81M -3.96M -4.1M
Comprehensive Income
n/a n/a n/a -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 0.00 -0.00 -0.00 -0.00 -0.00
Shareholders Equity
28.99M 27.52M 26.41M 23.46M 24.64M 24.99M 26.01M 26.86M 28.16M 30.38M 31.98M 32.77M 33.37M 32.58M 32.46M 32.27M 27.87M
Total Investments
n/a 50.4K -3.8B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -468 n/a n/a n/a